News- FDA Cuts Ambien Dosage in Half
The U.S. Food and Drug Administration (FDA) is requiring the makers of the sleep aid Zolpidem (marketed as Ambien) lower their dosing recommendations in light of new evidence which suggests the medications may affect user’s alertness the next morning following use.
Individuals who take this drug at night may experience impaired driving and/or alertness the next morning, posing a possible risk to themselves and those around them.
“FDA recommends that the bedtime dose be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving,” FDA.
The Risks of Ambien
“Patients who take insomnia drugs can experience impairment of mental alertness the morning after use, even if they feel fully awake,” FDA.
- According to the U.S Federal Drug Administration (FDA), all patients (men and women) who use Zolpidem products run the risk of mental impairment during activities (specifically driving) the following morning.
- Women are more susceptible to these risks due to the slower elimination of Zolpidem from their bodies in comparison to men.
- Due to these facts, U.S. health regulators have requested that the manufacturers of Zolpidem products (Ambien, Ambien CR, Edluar, and Zolpimist) decrease their recommended dose.
More Info on Zolpidem Sleep Aids
- According to the FDA, Zolpidem is a sedative-hypnotic medicine used for the purpose of treating insomnia in adults.
- Zolpidem is marketed as a generic and is also produced under the brand-names Ambien, Ambien CR, Edluar, Zolpimist, and Intermezzo.
- For the FDA recommendations on lower dosages, visit the FDA website.
Sleep Aids and Driving
- In recent years, there have been numerous reports of sleep aid users sleep eating, sleep driving, and performing other activities after taking their sleep medication.
- There have been several high-profile sleep-aid driving incidents, including those involving Commerce Secretary John Bryson and Kerry Kennedy, which resulted in users being arrested on suspicion of DUI.
- According to an article in Forbes, “there have been thousands of similar incidents reported in criminal dockets across the country and in the FDA’s Adverse Event Database.”
Contact An Experienced Sleeping Pill Injury Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
Your choice does matter. If you or a loved one has suffered serious injuries because of a prescription sleeping pill, call Thomas J. Henry immediately. We are available 24/7, nights and weekends.
AUTOMOBILE ACCIDENT RESULT
$1.8 MillionExpenses: $20,000.00 | Attorneys Fees: $765,000.00 | Net to Client: $1 Million
AUTOMOBILE ACCIDENT RESULTS
$2 MillionExpenses: $78,475.96 | Attorneys Fees: $850,087.96 | Net to Client: $1,071,436.00
AUTOMOBILE ACCIDENT RESULT
$2.3 MillionExpenses: $200,000.00 | Attorneys Fees: $900,000.00 | Net to Client: $1.2 Million